fingolimod hydrochloride has been researched along with Anasarca in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axelberg, H; Grände, PO; Lundblad, C | 1 |
| Chiu, AW; Chow, YC; Huang, CJ; Pan, WH; Shih, HJ; Wang, TY; Yen, JC | 1 |
| Andelova, M; Derfuss, T; Kappos, L; Lindberg, RL; Naegelin, Y; Rasenack, M; Rychen, J; Sprenger, T; Stippich, C | 1 |
| Brinkmann, V; Hengartner, H; Ochsenbein, AF; Odermatt, B; Pinschewer, DD; Zinkernagel, RM | 1 |
| Chiba, K; Imayoshi, T; Matsuura, M; Okumoto, T | 1 |
5 other study(ies) available for fingolimod hydrochloride and Anasarca
| Article | Year |
|---|---|
Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat.
Topics: Animals; Capillary Leak Syndrome; Capillary Permeability; Cecum; Disease Models, Animal; Diuresis; Drug Evaluation, Preclinical; Edema; Endothelium, Vascular; Fingolimod Hydrochloride; Hematocrit; Hemodynamics; Hemoglobins; Intestinal Perforation; Lysophospholipids; Male; Plasma Volume; Propylene Glycols; Random Allocation; Rats; Rats, Sprague-Dawley; Sepsis; Sphingosine | 2013 |
FTY720 mitigates torsion/detorsion-induced testicular injury in rats.
Topics: Animals; Drug Evaluation, Preclinical; Edema; Fingolimod Hydrochloride; Immunosuppressive Agents; Inflammation; Lipid Metabolism; Male; Neutrophil Infiltration; Propylene Glycols; Random Allocation; Rats, Sprague-Dawley; Spermatic Cord Torsion; Sphingosine; Testis | 2015 |
Efficacy and Safety of Fingolimod in an Unselected Patient Population.
Topics: Adult; Aged; Case-Control Studies; Cytokines; Dyspnea; Edema; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Retrospective Studies | 2016 |
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
Topics: Animals; Antibodies, Viral; Autoimmune Diseases; Cell Movement; Cytotoxicity, Immunologic; Diabetes Mellitus, Experimental; Edema; Fingolimod Hydrochloride; Hypersensitivity, Delayed; Immunologic Memory; Immunosuppressive Agents; Lymphocyte Activation; Lymphocyte Count; Lymphocytic choriomeningitis virus; Lymphopenia; Mice; Mice, Inbred C57BL; Mice, Transgenic; Propylene Glycols; Sphingosine; T-Lymphocytes, Cytotoxic | 2000 |
Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats.
Topics: Animals; Arthritis, Experimental; Cyclosporine; Edema; Fingolimod Hydrochloride; Immunosuppressive Agents; Leukocyte Count; Lymphocytes; Male; Monocytes; Mycobacterium tuberculosis; Neutrophils; Osteolysis; Propylene Glycols; Rats; Rats, Inbred Lew; Sphingosine; Tacrolimus | 2000 |